Horno N M, Alvarez E O
Laboratorio de Investigaciones Cerebrales (LINCE-CONICET), Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
J Neural Transm Gen Sect. 1989;78(3):249-64. doi: 10.1007/BF01249233.
The participation of histamine (HA) sensitive sites in the preoptic-anterior hypothalamic area (POA-AHA) on prolactin (PRL) and luteinizing hormone (LH) surge induced by estrogen was studied in ovariectomized rats. Different groups of animals were subjected to the following experimental schedule: On day "0" rats were stereotaxically implanted into the POA-AHA with microinjection cannulae. On day "1", rats were injected s.c. with estrogen. On days "2" and "3", animals were microinjected into the POA-AHA with different drugs, according to the type of experiment, and at day "4", through a silastic cannula implanted previously in the jugular vein, blood samples were taken each hour between 15:00-21:00 h. In the plasma, PRL and LH concentrations were measured by RIA. Four experiments were performed. In Experiment 1, animals at 12:00 h were injected into the POA-AHA with pyrilamine maleate (an H 1-histamine antagonist), metiamide (an H2-histamine antagonist) or saline as control. In Experiment 2, rats at 12:00 h were injected into the POA-AHA with alpha-fluormethyl-histidine (an inhibitor of histamine synthesis) or the combined administration of pyrilamine and metiamide. In Experiment 3, rats previously microinjected with the histamine synthesis inhibitor were microinjected with 4-methyl-histamine (an H 2-histamine agonists) or 2-pyridilethyl-amine (an H 1-histamine agonist) and in Experiment 4, rats were microinjected at 09:00 h with metiamide, pyrilamine, fluor-methyl-histidine or saline as control. Results showed that in animals treated with pyrilamine or metiamide at noon the prolactin surge induced by estrogen was affected (inhibited by metiamide and shortened by pyrilamine, Experiment 1) and LH surge slightly affected. Rats that received FMH or the combined administration of the histamine antagonists the prolactin and LH surge were abolished (Experiment 2). Only the treatment of the H 2-histamine agonist was able to reproduce the prolactin increase in rats treated with FMH. Nor the H 1 or H 2-histamine agonists were effective in reproducing the LH surge in these animals (Experiment 3). Animals that received saline at 09:00 h into the POA-AHA, the prolactin and LH surges were abolished. Results confirm that histamine in the POA-AHA is important for the expression of prolactin and LH surge induced by estrogen and suggest that H 1- and H 2-histamine receptors are involved in the complex timing mechanisms of the rostral hypothalamus that control both hormone release in rats.
在去卵巢大鼠中,研究了组胺(HA)敏感位点在视前区 - 下丘脑前区(POA - AHA)对雌激素诱导的催乳素(PRL)和促黄体生成素(LH)激增的参与情况。不同组的动物接受以下实验安排:在“0”天,大鼠通过立体定位将微量注射套管植入POA - AHA。在“1”天,大鼠皮下注射雌激素。在“2”天和“3”天,根据实验类型,将不同药物微量注射到POA - AHA中,在“4”天,通过先前植入颈静脉的硅橡胶套管,在15:00 - 21:00之间每小时采集血样。在血浆中,通过放射免疫分析法(RIA)测量PRL和LH浓度。进行了四项实验。在实验1中,在12:00将马来酸氯苯那敏(一种H1组胺拮抗剂)、甲硫咪胺(一种H2组胺拮抗剂)或生理盐水作为对照注射到POA - AHA中。在实验2中,在12:00将α - 氟甲基组氨酸(一种组胺合成抑制剂)或马来酸氯苯那敏和甲硫咪胺联合给药注射到POA - AHA中。在实验3中,先前微量注射了组胺合成抑制剂的大鼠再微量注射4 - 甲基组胺(一种H2组胺激动剂)或2 - 吡啶基乙胺(一种H1组胺激动剂),在实验4中,在09:00将甲硫咪胺、马来酸氯苯那敏、氟甲基组氨酸或生理盐水作为对照注射到POA - AHA中。结果表明,在中午用马来酸氯苯那敏或甲硫咪胺处理的动物中,雌激素诱导的催乳素激增受到影响(甲硫咪胺抑制,马来酸氯苯那敏缩短,实验1),LH激增受到轻微影响。接受氟甲基组氨酸或组胺拮抗剂联合给药的大鼠,催乳素和LH激增被消除(实验2)。仅用H2组胺激动剂处理能够使接受氟甲基组氨酸处理的大鼠重现催乳素增加。H1或H2组胺激动剂在这些动物中均不能有效重现LH激增(实验3)。在09:00将生理盐水注射到POA - AHA中的动物,催乳素和LH激增被消除。结果证实,POA - AHA中的组胺对于雌激素诱导的催乳素和LH激增的表达很重要,并表明H1和H2组胺受体参与了控制大鼠两种激素释放的下丘脑前部复杂的定时机制。